Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf336 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Christine L Hathaway und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Papillomaviridae. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, NIMH NIH HHS, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Background
Observational data on the synergy between human papillomavirus (HPV) infection and risk for HIV acquisition are needed. HPV clearance, associated with an influx of cells targeted by HIV, may increase HIV risk. This study examined the association between HPV and HIV acquisition using endocervical swabs collected in MTN-020/ASPIRE.
Methods
Healthy, sexually active women without HIV participating in the ASPIRE dapivirine ring study in Malawi, South Africa, Uganda, and Zimbabwe provided endocervical swabs monthly, which were tested for HPV-DNA. HPV status was classified into prevalent, persistent (HPV+ for at least 4 months), HPV clearance (HPV+ followed by HPV−), HPV acquisition (HPV− followed by HPV+), and remaining HPV positive (2 subsequent HPV+). Cox time-varying regression models were used to assess associations between HPV states and HIV acquisition.
Results
Among 91 HIV acquisition endpoints, HPV clearance increased HIV risk for high-risk types (16/18/31/33/35/45/52/58) (HR = 2.40, 95% CI = 1.59 to 3.62). Remaining HPV+ also showed a moderately increased risk (HR = 1.59, 95% CI = 1.07 to 2.35), while prevalent, persistent, and HPV acquisition events showed non-significant associations. Elevated HIV risk was also observed for clearance of HPV16/18, other high-risk types, low-risk types, and HPV6/11. There was also a dose-response relationship, with HIV risk increasing by 1.75-fold (95% CI = 1.55 to 1.96) for each additional HPV type cleared.
Conclusions
HPV clearance-related immune activation is strongly linked to HIV acquisition, likely due to increased CD4+ T cells and inflammation. These findings support HPV vaccination as a potential HIV prevention strategy and highlight the need to integrate HIV prevention into cervical cancer programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States.
- University of Washington School of Medicine, Seattle, WA, United States.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
- Department of Biostatistics, University of Washington, Seattle, WA, United States.
- Department of Laboratory Medicine and Pathology, Harborview Medical Center, Seattle, WA, United States.
- University of Texas Rio Grande Valley School of Medicine, Edinburg, TX, United States.
ORCID-Profile: Christine L Hathaway, Elizabeth R Brown, Zvavahera M Chirenje, Kubashni Woeber, Zakir Gaffoor, Flavia Matovu Kiweewa, Leila E Mansoor, Lameck Chinula, Thesla Palanee-Phillips, Ruanne V Barnabas
Förderung
- National Institute of Allergy and Infectious Diseases
- NIMH NIH HHS
- Bill and Melinda Gates Foundation
- NIAID NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH HHS
- Microbicide Trials Network
- National Institute of Mental Health
Zitieren
APA
Hathaway, C. L., Brown, E. R., Cherne, S., Sepulveda, A. L., Chirenje, Z. M., Jeenarain, N., Naidoo, L., Siva, S., Singh, N., Woeber, K., Gaffoor, Z., Mirembe, B. G., Kiweewa, F. M., Mansoor, L. E., Chinula, L., Dadabhai, S., Mugo, N. R., Palanee-Phillips, T., & Barnabas, R. V. (2025). Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf336
Vancouver
Hathaway CL, Brown ER, Cherne S, Sepulveda AL, Chirenje ZM, Jeenarain N, et al. Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf336
BibTeX
@article{Hathaway2025,
author = {Hathaway, Christine L and Brown, Elizabeth R and Cherne, Stephen and Sepulveda, Alyssa L and Chirenje, Zvavahera M and Jeenarain, Nitesha and Naidoo, Logashvari and Siva, Samantha and Singh, Nishanta and Woeber, Kubashni and Gaffoor, Zakir and Mirembe, Brenda Gati and Kiweewa, Flavia Matovu and Mansoor, Leila E and Chinula, Lameck and Dadabhai, Sufia and Mugo, Nelly R and Palanee-Phillips, Thesla and Barnabas, Ruanne V},
title = {Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf336}
}
EUVIMED